Fear of cancer recurrence therapy (FORT): A randomized controlled trial.

Christine MaheuSophie LebelLori J BernsteinChristine CourbassonMina SinghSarah E FergusonCheryl HarrisLynne JolicoeurLorena BakuLinda MuracaAgnihotram V RamanakumarFrederic LamondeMonique LefebvreChristina TomeiBrittany MutsaersScott SecordJoanne PowerNancy DrummondMaude HébertRajvi J Wani

Published in: Health psychology : official journal of the Division of Health Psychology, American Psychological Association (2023)

This RCT demonstrated that FORT, compared to an attention placebo control group, resulted in a greater reduction in FCR posttreatment and at 3 months posttreatment in women with breast and gynecological cancer, indicating its potential as a new treatment strategy. We recommend a booster session to sustain gains. (PsycInfo Database Record (c) 2023 APA, all rights reserved).

Keyphrases

papillary thyroid
squamous cell
working memory
clinical trial
randomized controlled trial
stem cells
young adults
high intensity
adverse drug
free survival
cell therapy
combination therapy
electronic health record